NurOwn Shows Potential In Preclinical Autism Model
April 19, 2017 at 14:20 PM EDT
BrainStorm’s next step in the development of NurOwn is to initiate a Phase 3 clinical study in the U.S. This will be a major milestone for the company and establish an important Catalyst for the shares once initiated.
